+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Generic Drugs Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Molecule Type, Indication, Type, Distribution Channel, and Geography- Product Image
Generic Drugs Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Molecule Type, Indication, Type, Distribution Channel, and Geography- Product Image
New

Generic Drugs Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Molecule Type, Indication, Type, Distribution Channel, and Geography

  • PDF Icon

    Report

  • 287 Pages
  • May 2025
  • Region: Global
  • The Insight Partners
  • ID: 6091417
Description Jump to:
According to our new research study on “Global Generic Drugs Forecast to 2031 - Global Analysis - by Molecule Type, Indication, Type, and Distribution Channel,” the market was valued at US$ 423.55 billion in 2024 and is projected to reach US$ 594.99 billion by 2031; it is expected to register a CAGR of 5.0% from during 2025- to 2031. Major factors driving the generic drugs market growth include the presence of government policies and regulatory support for generics and, patent expiry and loss of market exclusivity.

Generic drugs are medications that contain the same active ingredients as brand-name drugs and are intended to work in the same way, with the same dosage, strength, route of administration, quality, and performance characteristics. They are typically introduced after the patent protection of the original branded drug has expired, allowing other manufacturers to produce and market the drug at a lower cost. Generic drugs are approved by regulatory authorities-such as the FDA in the U.S.

or CDSCO in India-after proving they are bioequivalent to the branded version, meaning they deliver the same amount of active substance into a patient’s bloodstream in the same time frame. Because they do not require the same level of investment in research, development, and marketing as new drugs, generic medicines are often significantly more affordable, playing a crucial role in improving access to healthcare, especially in low- and middle-income countries.

The generic drugs market in North America is expanding steadily, driven by rising healthcare costs, a growing population, surging patent expirations of branded drugs, and increasing demand for affordable treatment options. The US, Canada, and Mexico are the key contributors, with the US holding the largest market share. By 2030, one in five Americans will be over 65, increasing the need for cost-effective treatments for chronic conditions such as diabetes, hypertension, and arthritis. Government support and regulatory pathways also strengthen the market. Agencies such as the US FDA have accelerated approval pathways for generic drugs, ensuring faster access without compromising safety or efficacy.

This has made it easier for manufacturers to bring generics to market. Another driver is the focus on healthcare cost containment. Payers and policymakers promote the use of generics to reduce overall spending. According to the Association for Accessible Medicines, generics accounted for 90% of prescriptions dispensed in the US and 18% of drug spending in 2023. The market is also seeing increased competition and consolidation. Market players are expanding portfolios through partnerships and acquisitions to gain scale and meet rising demand. In North America, the US holds the highest share of the pharmaceutical membrane filters market.

The US pharmaceutical membrane filters market is witnessing robust growth driven by increasing pharmaceutical and biopharmaceutical production, stringent regulatory guidelines for sterile filtration, and rising demand for high-purity filtration solutions. As per Ibis World, in 2024, the United States was home to approximately 2,432 biotechnology companies; likewise, in the contract research organization (CRO) sector, about 4,321 businesses are operating in the US.

The generic drugs market in the US is experiencing strong growth, fueled by the rising burden of chronic illnesses, cancer, and infectious diseases, along with a push for affordable healthcare solutions. In 2024, ~2 million new cancer cases were diagnosed, up from 1.9 million in 2022, with ~0.61 million deaths, underscoring the urgent need for cost-effective treatments.

While innovative options such as therapeutic cancer vaccines (e.g., Provenge for prostate cancer), neoantigen-based vaccines for triple-negative breast cancer, and mRNA vaccines such as autogene cevumeran for pancreatic cancer are showing promising results-with trials reporting up to 88% of patients remaining cancer-free after three years-the affordability and accessibility provided by generic drugs remain vital to large-scale public health impact. Generics play a pivotal role once patents expire, making life-saving medications accessible to a broader population. The US biopharmaceutical industry, which includes generic manufacturers, is a global leader in innovation and scale.

According to the Pharmaceutical Research and Manufacturers of America, in 2022, the industry generated over USUS$ 800 billion in direct output and USUS$ 1.65 trillion in total economic contribution-about 3.6% of the US economy. Also, the industry invested US$141 billion in domestic R&D, representing 78.6% of all US industry-funded medical research, and operated 1,574 facilities producing FDA-approved products under strict GMP guidelines.

Policy measures such as the Inflation Reduction Act (IRA) of 2022 are reshaping the pricing landscape. In 2024, the US government finalized negotiations to reduce prices on the first 10 drugs, including widely used medications such as Eliquis, Stelara, and Jardiance, by 38% to 79%. These reforms are projected to save US taxpayers US$6 billion and provide US$1.5 billion in patient savings by 2026. The expanding demand, policy support, strong regulatory oversight, and manufacturing capabilities are positioning the US generic drug market as a backbone of the healthcare system-offering safe, effective, and affordable treatments.

Rising Popularity of Biosimilars in the Global Generic Drugs Market to Provide Market trends in Future

Biosimilars are gaining prominence in the global generic drugs market, influenced by several key trends. The expiration of patents for major biologic drugs has paved the way for biosimilars, offering more affordable alternatives and contributing to reduced healthcare costs. Regulatory agencies such as the FDA and EMA have established streamlined approval processes for biosimilars, facilitating their timely market entry. This has led to increased acceptance among healthcare providers, supported by real-world evidence and successful clinical trials demonstrating their safety and efficacy. As more biologic patents expire, the market has become more competitive, prompting pharmaceutical companies to invest in biosimilar development.

Additionally, biosimilars are gaining traction in emerging markets, enhancing access to essential biologic treatments at reduced costs. As per the WHO, noncommunicable diseases (NCDs), including cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes, are the leading causes of death and disability worldwide. In 2019, NCDs accounted for 41 million of the 55 million global deaths, representing 75% of all deaths that year.

Furthermore, ~18 million NCD-related deaths occurred before the age of 70, with 82% of these premature deaths in low- and middle-income countries. As per the UN, the global burden of NCDs is projected to increase, with estimates suggesting that by 2050, chronic diseases will account for 86% of the 90 million deaths annually, a 90% increase in absolute numbers since 2019.

As per ETworldhealth, In India, hypertension and diabetes constitute about 68% of all chronic diseases. Other prevalent chronic conditions include arthritis, lung diseases, heart diseases or strokes, neurological disorders, and cancers. Major risk factors contributing to these diseases in India encompass undernutrition, air pollution, unhealthy diets, high blood pressure, elevated blood glucose levels, high cholesterol, and obesity.

The escalating prevalence of chronic diseases underscores the critical need for effective prevention and management strategies. Biosimilars play a vital role in this context by providing cost-effective treatment options, thereby improving access to necessary therapies and alleviating the financial burden on healthcare systems and patients.

Some of the developments are:

In 2023, Teva introduced an authorized generic of liraglutide injection 1.8mg, equivalent to Victoza, in the United States. This medication is used to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus and to reduce the risk of cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease.

In 2024, Viatris developed a new version of Viagra called Viagra ODF, a wafer-like film that dissolves in the mouth without the need for water. This discreet form offers a more convenient alternative to the traditional pill. The company applied for a trademark in the UK, suggesting the product might hit the market within the next five years. Viagra ODF was launched in Canada in September and is expected to cost similarly to traditional Viagra.

In 2023, Dr. Reddy's entered into a definitive agreement to acquire the U.S. generic prescription product portfolio of Australia-based Mayne Pharma Group for $105 million. The portfolio includes 45 commercial products, four pipeline products, and 40 approved non-marketed products, including generics focused on women's health.

Reasons to buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global generic drugs market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global generic drugs market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the global generic drugs market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table of Contents

1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Analyst Market Outlook
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Generic Drugs Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Regulatory Landscape
4.3.1 North America
4.3.1.1 United States
4.3.1.2 Canada
4.3.1.3 Mexico
4.3.2 Europe
4.3.3 Asia Pacific
4.3.3.1 India
4.3.3.2 China
4.3.3.3 Japan
4.3.3.4 South Korea
4.3.3.5 Australia
4.3.4 Middle East and Africa
4.3.4.1 Saudi Arabia
4.3.4.2 South Africa
4.3.4.3 United Arab Emirates (UAE)
4.3.5 South and Central America
4.3.5.1 Brazil
4.4 Top 10 Blockbuster Drugs Facing Patent Expiry in the Next 5 Years with Revenue Data and Market Impact:
4.5 Average Selling Price, 2024
4.6 Pipeline Analysis:
5. Generic Drugs Market - Key Market Dynamics
5.1 Generic Drugs Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Patent Expiry and Loss of Market Exclusivity:
5.2.2 Government Policies and Regulatory Support for Generics
5.3 Market Restraints
5.3.1 Intense Price Competition and Thin Profit Margins
5.4 Market Opportunities
5.4.1 Increasing Government Initiatives to promote the use of generic drugs
5.5 Future Trends
5.5.1 Rising Popularity of Biosimilars in the Global Generic Drugs Market
5.6 Impact of Drivers and Restraints:
6. Generic Drugs Market - Global Market Analysis
6.1 Generic Drugs Market Revenue (US$ Billion), 2021-2031
6.2 Generic Drugs Market Forecast Analysis
7. Generic Drugs Market Analysis - by Molecule Type
7.1 Antidepressants
7.1.1 Overview
7.1.2 Antidepressants: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
7.2 Antihistamines
7.2.1 Overview
7.2.2 Antihistamines: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
7.3 Analgesics
7.3.1 Overview
7.3.2 Analgesics: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
7.4 Antibiotics
7.4.1 Overview
7.4.2 Antibiotics: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
7.5 Antivirals
7.5.1 Overview
7.5.2 Antivirals: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
7.6 Diuretics
7.6.1 Overview
7.6.2 Diuretics: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
7.7 Others
7.7.1 Overview
7.7.2 Others: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
8. Generic Drugs Market Analysis - by Indication
8.1 Metabolic Diseases
8.1.1 Overview
8.1.2 Metabolic Diseases: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
8.2 Cancer
8.2.1 Overview
8.2.2 Cancer: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
8.3 Immunology
8.3.1 Overview
8.3.2 Immunology: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
8.4 Respiratory Disorder
8.4.1 Overview
8.4.2 Respiratory Disorder: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
8.5 Cardiovascular Disorder
8.5.1 Overview
8.5.2 Cardiovascular Disorder: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
8.6 Neurology Disorder
8.6.1 Overview
8.6.2 Neurology Disorder: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
8.7 Rare Disease
8.7.1 Overview
8.7.2 Rare Disease: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
8.8 Others
8.8.1 Overview
8.8.2 Others: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
9. Generic Drugs Market Analysis - by Type
9.1 Prescription
9.1.1 Overview
9.1.2 Prescription: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
9.2 OTC Drugs
9.2.1 Overview
9.2.2 OTC Drugs: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
10. Generic Drugs Market Analysis - by Distribution Channel
10.1 Hospital Pharmacies
10.1.1 Overview
10.1.2 Hospital Pharmacies: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
10.2 Retail Pharmacies
10.2.1 Overview
10.2.2 Retail Pharmacies: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
10.3 Online Pharmacies
10.3.1 Overview
10.3.2 Online Pharmacies: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
11. Generic Drugs Market - Geographical Analysis
11.1 Overview
11.2 North America
11.2.1 North America Generic Drugs Market Overview
11.2.2 North America: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
11.2.2.1 North America: Generic Drugs Market - Revenue and Forecast Analysis - by Molecule Type
11.2.2.2 North America: Generic Drugs Market - Revenue and Forecast Analysis - by Indication
11.2.2.3 North America: Generic Drugs Market - Revenue and Forecast Analysis - by Type
11.2.2.4 North America: Generic Drugs Market - Revenue and Forecast Analysis - by Distribution Channel
11.2.3 North America: Generic Drugs Market - Revenue and Forecast Analysis - by Country0
11.2.3.1 United States: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)0
11.2.3.1.1 United States: Generic Drugs Market Breakdown, by Molecule Type1
11.2.3.1.2 United States: Generic Drugs Market Breakdown, by Indication2
11.2.3.1.3 United States: Generic Drugs Market Breakdown, by Type3
11.2.3.1.4 United States: Generic Drugs Market Breakdown, by Distribution Channel4
11.2.3.2 Canada: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)5
11.2.3.2.1 Canada: Generic Drugs Market Breakdown, by Molecule Type6
11.2.3.2.2 Canada: Generic Drugs Market Breakdown, by Indication7
11.2.3.2.3 Canada: Generic Drugs Market Breakdown, by Type8
11.2.3.2.4 Canada: Generic Drugs Market Breakdown, by Distribution Channel8
11.2.3.3 Mexico: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)9
11.2.3.3.1 Mexico: Generic Drugs Market Breakdown, by Molecule Type0
11.2.3.3.2 Mexico: Generic Drugs Market Breakdown, by Indication1
11.2.3.3.3 Mexico: Generic Drugs Market Breakdown, by Type2
11.2.3.3.4 Mexico: Generic Drugs Market Breakdown, by Distribution Channel3
11.3 Europe4
11.3.1 Europe Generic Drugs Market Overview4
11.3.2 Europe: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)4
11.3.2.1 Europe: Generic Drugs Market - Revenue and Forecast Analysis - by Molecule Type5
11.3.2.2 Europe: Generic Drugs Market - Revenue and Forecast Analysis - by Indication6
11.3.2.3 Europe: Generic Drugs Market - Revenue and Forecast Analysis - by Type7
11.3.2.4 Europe: Generic Drugs Market - Revenue and Forecast Analysis - by Distribution Channel7
11.3.3 Europe: Generic Drugs Market - Revenue and Forecast Analysis - by Country8
11.3.3.1 United Kingdom: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)9
11.3.3.1.1 United Kingdom: Generic Drugs Market Breakdown, by Molecule Type0
11.3.3.1.2 United Kingdom: Generic Drugs Market Breakdown, by Indication1
11.3.3.1.3 United Kingdom: Generic Drugs Market Breakdown, by Type2
11.3.3.1.4 United Kingdom: Generic Drugs Market Breakdown, by Distribution Channel2
11.3.3.2 Germany: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)3
11.3.3.2.1 Germany: Generic Drugs Market Breakdown, by Molecule Type4
11.3.3.2.2 Germany: Generic Drugs Market Breakdown, by Indication5
11.3.3.2.3 Germany: Generic Drugs Market Breakdown, by Type6
11.3.3.2.4 Germany: Generic Drugs Market Breakdown, by Distribution Channel7
11.3.3.3 France: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)8
11.3.3.3.1 France: Generic Drugs Market Breakdown, by Molecule Type9
11.3.3.3.2 France: Generic Drugs Market Breakdown, by Indication0
11.3.3.3.3 France: Generic Drugs Market Breakdown, by Type1
11.3.3.3.4 France: Generic Drugs Market Breakdown, by Distribution Channel1
11.3.3.4 Italy: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)3
11.3.3.4.1 Italy: Generic Drugs Market Breakdown, by Molecule Type4
11.3.3.4.2 Italy: Generic Drugs Market Breakdown, by Indication5
11.3.3.4.3 Italy: Generic Drugs Market Breakdown, by Type6
11.3.3.4.4 Italy: Generic Drugs Market Breakdown, by Distribution Channel7
11.3.3.5 Spain: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)8
11.3.3.5.1 Spain: Generic Drugs Market Breakdown, by Molecule Type9
11.3.3.5.2 Spain: Generic Drugs Market Breakdown, by Indication0
11.3.3.5.3 Spain: Generic Drugs Market Breakdown, by Type1
11.3.3.5.4 Spain: Generic Drugs Market Breakdown, by Distribution Channel1
11.3.3.6 Rest of Europe: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)2
11.3.3.6.1 Rest of Europe: Generic Drugs Market Breakdown, by Molecule Type3
11.3.3.6.2 Rest of Europe: Generic Drugs Market Breakdown, by Indication4
11.3.3.6.3 Rest of Europe: Generic Drugs Market Breakdown, by Type5
11.3.3.6.4 Rest of Europe: Generic Drugs Market Breakdown, by Distribution Channel6
11.4 Asia Pacific7
11.4.1 Asia Pacific Generic Drugs Market Overview7
11.4.2 Asia Pacific: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)7
11.4.3 Asia Pacific: Generic Drugs Market Breakdown, by Molecule Type8
11.4.3.1 Asia Pacific: Generic Drugs Market - Revenue and Forecast Analysis - by Molecule Type8
11.4.3.2 Asia Pacific: Generic Drugs Market - Revenue and Forecast Analysis - by Indication9
11.4.3.3 Asia Pacific: Generic Drugs Market - Revenue and Forecast Analysis - by Type0
11.4.3.4 Asia Pacific: Generic Drugs Market - Revenue and Forecast Analysis - by Distribution Channel1
11.4.4 Asia Pacific: Generic Drugs Market - Revenue and Forecast Analysis - by Country2
11.4.4.1 China: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)2
11.4.4.1.1 China: Generic Drugs Market Breakdown, by Molecule Type3
11.4.4.1.2 China: Generic Drugs Market Breakdown, by Indication4
11.4.4.1.3 China: Generic Drugs Market Breakdown, by Type5
11.4.4.1.4 China: Generic Drugs Market Breakdown, by Distribution Channel6
11.4.4.2 Japan: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)7
11.4.4.2.1 Japan: Generic Drugs Market Breakdown, by Molecule Type8
11.4.4.2.2 Japan: Generic Drugs Market Breakdown, by Indication9
11.4.4.2.3 Japan: Generic Drugs Market Breakdown, by Type0
11.4.4.2.4 Japan: Generic Drugs Market Breakdown, by Distribution Channel0
11.4.4.3 India: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)1
11.4.4.3.1 India: Generic Drugs Market Breakdown, by Molecule Type2
11.4.4.3.2 India: Generic Drugs Market Breakdown, by Indication3
11.4.4.3.3 India: Generic Drugs Market Breakdown, by Type4
11.4.4.3.4 India: Generic Drugs Market Breakdown, by Distribution Channel5
11.4.4.4 Australia: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)6
11.4.4.4.1 Australia: Generic Drugs Market Breakdown, by Molecule Type7
11.4.4.4.2 Australia: Generic Drugs Market Breakdown, by Indication8
11.4.4.4.3 Australia: Generic Drugs Market Breakdown, by Type9
11.4.4.4.4 Australia: Generic Drugs Market Breakdown, by Distribution Channel9
11.4.4.5 South Korea: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)0
11.4.4.5.1 South Korea: Generic Drugs Market Breakdown, by Molecule Type1
11.4.4.5.2 South Korea: Generic Drugs Market Breakdown, by Indication2
11.4.4.5.3 South Korea: Generic Drugs Market Breakdown, by Type3
11.4.4.5.4 South Korea: Generic Drugs Market Breakdown, by Distribution Channel4
11.4.4.6 Rest of APAC: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)5
11.4.4.6.1 Rest of APAC: Generic Drugs Market Breakdown, by Molecule Type6
11.4.4.6.2 Rest of APAC: Generic Drugs Market Breakdown, by Indication7
11.4.4.6.3 Rest of APAC: Generic Drugs Market Breakdown, by Type8
11.4.4.6.4 Rest of APAC: Generic Drugs Market Breakdown, by Distribution Channel8
11.5 Middle East and Africa1
11.5.1 Middle East and Africa Generic Drugs Market Overview1
11.5.2 Middle East and Africa: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)1
11.5.2.1 Middle East and Africa: Generic Drugs Market - Revenue and Forecast Analysis - by Molecule Type2
11.5.2.2 Middle East and Africa: Generic Drugs Market - Revenue and Forecast Analysis - by Indication3
11.5.2.3 Middle East and Africa: Generic Drugs Market - Revenue and Forecast Analysis - by Type4
11.5.2.4 Middle East and Africa: Generic Drugs Market - Revenue and Forecast Analysis - by Distribution Channel4
11.5.3 Middle East and Africa: Generic Drugs Market - Revenue and Forecast Analysis - by Country5
11.5.3.1 Saudi Arabia: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)6
11.5.3.1.1 Saudi Arabia: Generic Drugs Market Breakdown, by Molecule Type7
11.5.3.1.2 Saudi Arabia: Generic Drugs Market Breakdown, by Indication8
11.5.3.1.3 Saudi Arabia: Generic Drugs Market Breakdown, by Type9
11.5.3.1.4 Saudi Arabia: Generic Drugs Market Breakdown, by Distribution Channel9
11.5.3.2 South Africa: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)1
11.5.3.2.1 South Africa: Generic Drugs Market Breakdown, by Molecule Type2
11.5.3.2.2 South Africa: Generic Drugs Market Breakdown, by Indication3
11.5.3.2.3 South Africa: Generic Drugs Market Breakdown, by Type4
11.5.3.2.4 South Africa: Generic Drugs Market Breakdown, by Distribution Channel5
11.5.3.3 United Arab Emirates: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)6
11.5.3.3.1 United Arab Emirates: Generic Drugs Market Breakdown, by Molecule Type7
11.5.3.3.2 United Arab Emirates: Generic Drugs Market Breakdown, by Indication8
11.5.3.3.3 United Arab Emirates: Generic Drugs Market Breakdown, by Type9
11.5.3.3.4 United Arab Emirates: Generic Drugs Market Breakdown, by Distribution Channel9
11.5.3.4 Rest of Middle East and Africa: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)0
11.5.3.4.1 Rest of Middle East and Africa: Generic Drugs Market Breakdown, by Molecule Type1
11.5.3.4.2 Rest of Middle East and Africa: Generic Drugs Market Breakdown, by Indication2
11.5.3.4.3 Rest of Middle East and Africa: Generic Drugs Market Breakdown, by Type3
11.5.3.4.4 Rest of Middle East and Africa: Generic Drugs Market Breakdown, by Distribution Channel4
11.6 South and Central America5
11.6.1 South and Central America Generic Drugs Market Overview5
11.6.2 South and Central America: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)5
11.6.2.1 South and Central America: Generic Drugs Market - Revenue and Forecast Analysis - by Molecule Type6
11.6.2.2 South and Central America: Generic Drugs Market - Revenue and Forecast Analysis - by Indication7
11.6.2.3 South and Central America: Generic Drugs Market - Revenue and Forecast Analysis - by Type8
11.6.2.4 South and Central America: Generic Drugs Market - Revenue and Forecast Analysis - by Distribution Channel9
11.6.3 South and Central America: Generic Drugs Market - Revenue and Forecast Analysis - by Country0
11.6.3.1 Brazil: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)0
11.6.3.1.1 Brazil: Generic Drugs Market Breakdown, by Molecule Type1
11.6.3.1.2 Brazil: Generic Drugs Market Breakdown, by Indication2
11.6.3.1.3 Brazil: Generic Drugs Market Breakdown, by Type3
11.6.3.1.4 Brazil: Generic Drugs Market Breakdown, by Distribution Channel4
11.6.3.2 Argentina: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)5
11.6.3.2.1 Argentina: Generic Drugs Market Breakdown, by Molecule Type6
11.6.3.2.2 Argentina: Generic Drugs Market Breakdown, by Indication7
11.6.3.2.3 Argentina: Generic Drugs Market Breakdown, by Type8
11.6.3.2.4 Argentina: Generic Drugs Market Breakdown, by Distribution Channel8
11.6.3.3 Rest of South and Central America: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)9
11.6.3.3.1 Rest of South and Central America: Generic Drugs Market Breakdown, by Indication1
11.6.3.3.2 Rest of South and Central America: Generic Drugs Market Breakdown, by Type2
11.6.3.3.3 Rest of South and Central America: Generic Drugs Market Breakdown, by Distribution Channel2
12. Industry Landscape4
12.1 Overview4
12.2 Expansion4
12.3 New Product Development/ Launch/ Approvals4
12.4 Merger and Acquisition/Partnership5
12.5 Other Business Strategies5
13. Company Profiles6
13.1 Teva Pharmaceutical Industries Ltd6
13.1.1 Key Facts6
13.1.2 Business Description6
13.1.3 Products and Services7
13.1.4 Financial Overview7
13.1.5 SWOT Analysis8
13.1.6 Key Developments9
13.2 Viatris Inc1
13.2.1 Key Facts1
13.2.2 Business Description1
13.2.3 Products and Services2
13.2.4 Financial Overview2
13.2.5 SWOT Analysis3
13.2.6 Key Developments5
13.3 Dr. Reddy's Laboratories Ltd6
13.3.1 Key Facts6
13.3.2 Business Description6
13.3.3 Products and Services6
13.3.4 Financial Overview7
13.3.5 SWOT Analysis8
13.3.6 Key Developments9
13.4 Novartis AG0
13.4.1 Key Facts0
13.4.2 Business Description0
13.4.3 Products and Services1
13.4.4 Financial Overview1
13.4.5 SWOT Analysis2
13.4.6 Key Developments4
13.5 Sun Pharmaceutical Industries Ltd5
13.5.1 Key Facts5
13.5.2 Business Description5
13.5.3 Products and Services6
13.5.4 Financial Overview6
13.5.5 SWOT Analysis7
13.5.6 Key Developments8
13.6 AbbVie Inc9
13.6.1 Key Facts9
13.6.2 Business Description9
13.6.3 Products and Services0
13.6.4 Financial Overview0
13.6.5 SWOT Analysis1
13.6.6 Key Developments2
13.7 AstraZeneca Plc3
13.7.1 Key Facts3
13.7.2 Business Description3
13.7.3 Products and Services4
13.7.4 Financial Overview4
13.7.5 SWOT Analysis6
13.7.6 Key Developments7
13.8 Sanofi SA8
13.8.1 Key Facts8
13.8.2 Business Description8
13.8.3 Products and Services9
13.8.4 Financial Overview9
13.8.5 SWOT Analysis0
13.8.6 Key Developments2
13.9 Aurobindo Pharma Ltd3
13.9.1 Key Facts3
13.9.2 Business Description3
13.9.3 Products and Services3
13.9.4 Financial Overview4
13.9.5 SWOT Analysis5
13.9.6 Key Developments6
13.10 Glenmark Pharmaceuticals Ltd7
13.10.1 Key Facts7
13.10.2 Business Description7
13.10.3 Products and Services7
13.10.4 Financial Overview8
13.10.5 SWOT Analysis8
13.10.6 Key Developments9
14. Appendix0
14.1 Glossary of Terms0
14.2 About the Publisher2
List of Tables
Table 1. Generic Drugs Market Segmentation
Table 2. Generic Drugs Market - Revenue, 2021 - 2024 (US$ Billion)
Table 3. Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion)
Table 4. Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type
Table 5. Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 6. Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication
Table 7. Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 8. Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type
Table 9. Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 10. Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel
Table 11. Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel0
Table 12. North America: Generic Drugs Market - Revenue, 2021 - 2024 (US$ Billion) - by Molecule Type7
Table 13. North America: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type8
Table 14. North America: Generic Drugs Market - Revenue, 2021 - 2024 (US$ Billion) - by Indication8
Table 15. North America: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication9
Table 16. North America: Generic Drugs Market - Revenue, 2021 - 2024 (US$ Billion) - by Type9
Table 17. North America: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type0
Table 18. North America: Generic Drugs Market - Revenue, 2021 - 2024 (US$ Billion) - by Distribution Channel0
Table 19. North America: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel0
Table 20. United States: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type2
Table 21. United States: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type3
Table 22. United States: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication3
Table 23. United States: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication4
Table 24. United States: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type4
Table 25. United States: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type4
Table 26. United States: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel5
Table 27. United States: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel5
Table 28. Canada: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type7
Table 29. Canada: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type7
Table 30. Canada: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication8
Table 31. Canada: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication8
Table 32. Canada: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type9
Table 33. Canada: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type9
Table 34. Canada: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel9
Table 35. Canada: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel0
Table 36. Mexico: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type1
Table 37. Mexico: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type2
Table 38. Mexico: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication2
Table 39. Mexico: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication3
Table 40. Mexico: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type3
Table 41. Mexico: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type3
Table 42. Mexico: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel4
Table 43. Mexico: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel4
Table 44. Europe: Generic Drugs Market - Revenue, 2021 - 2024 (US$ Billion) - by Molecule Type6
Table 45. Europe: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type6
Table 46. Europe: Generic Drugs Market - Revenue, 2021 - 2024 (US$ Billion) - by Indication7
Table 47. Europe: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication7
Table 48. Europe: Generic Drugs Market - Revenue, 2021 - 2024 (US$ Billion) - by Type8
Table 49. Europe: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type8
Table 50. Europe: Generic Drugs Market - Revenue, 2021 - 2024 (US$ Billion) - by Distribution Channel8
Table 51. Europe: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel9
Table 52. United Kingdom: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type1
Table 53. United Kingdom: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type1
Table 54. United Kingdom: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication2
Table 55. United Kingdom: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication2
Table 56. United Kingdom: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type3
Table 57. United Kingdom: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type3
Table 58. United Kingdom: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel3
Table 59. United Kingdom: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel4
Table 60. Germany: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type5
Table 61. Germany: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type6
Table 62. Germany: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication6
Table 63. Germany: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication7
Table 64. Germany: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type7
Table 65. Germany: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type8
Table 66. Germany: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel8
Table 67. Germany: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel8
Table 68. France: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type0
Table 69. France: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type0
Table 70. France: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication1
Table 71. France: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication1
Table 72. France: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type2
Table 73. France: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type2
Table 74. France: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel2
Table 75. France: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel4
Table 76. Italy: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type5
Table 77. Italy: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type6
Table 78. Italy: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication6
Table 79. Italy: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication7
Table 80. Italy: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type7
Table 81. Italy: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type7
Table 82. Italy: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel8
Table 83. Italy: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel8
Table 84. Spain: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type0
Table 85. Spain: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type0
Table 86. Spain: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication1
Table 87. Spain: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication1
Table 88. Spain: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type2
Table 89. Spain: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type2
Table 90. Spain: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel2
Table 91. Spain: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel3
Table 92. Rest of Europe: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type4
Table 93. Rest of Europe: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type5
Table 94. Rest of Europe: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication5
Table 95. Rest of Europe: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication6
Table 96. Rest of Europe: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type6
Table 97. Rest of Europe: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type6
Table 98. Rest of Europe: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel7
Table 99. Rest of Europe: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel7
Table 100. Asia Pacific: Generic Drugs Market - Revenue, 2021 - 2024 (US$ Billion) - by Molecule Type9
Table 101. Asia Pacific: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type9
Table 102. Asia Pacific: Generic Drugs Market - Revenue, 2021 - 2024 (US$ Billion) - by Indication0
Table 103. Asia Pacific: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication1
Table 104. Asia Pacific: Generic Drugs Market - Revenue, 2021 - 2024 (US$ Billion) - by Type1
Table 105. Asia Pacific: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type1
Table 106. Asia Pacific: Generic Drugs Market - Revenue, 2021 - 2024 (US$ Billion) - by Distribution Channel2
Table 107. Asia Pacific: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel2
Table 108. China: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type4
Table 109. China: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type5
Table 110. China: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication5
Table 111. China: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication6
Table 112. China: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type6
Table 113. China: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type6
Table 114. China: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel7
Table 115. China: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel7
Table 116. Japan: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type9
Table 117. Japan: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type9
Table 118. Japan: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication0
Table 119. Japan: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication0
Table 120. Japan: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type1
Table 121. Japan: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type1
Table 122. Japan: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel1
Table 123. Japan: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel2
Table 124. India: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type3
Table 125. India: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type4
Table 126. India: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication4
Table 127. India: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication5
Table 128. India: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type5
Table 129. India: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type5
Table 130. India: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel6
Table 131. India: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel6
Table 132. Australia: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type8
Table 133. Australia: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type8
Table 134. Australia: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication9
Table 135. Australia: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication9
Table 136. Australia: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type0
Table 137. Australia: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type0
Table 138. Australia: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel0
Table 139. Australia: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel1
Table 140. South Korea: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type2
Table 141. South Korea: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type3
Table 142. South Korea: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication3
Table 143. South Korea: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication4
Table 144. South Korea: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type4
Table 145. South Korea: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type4
Table 146. South Korea: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel5
Table 147. South Korea: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel5
Table 148. Rest of APAC: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type7
Table 149. Rest of APAC: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type7
Table 150. Rest of APAC: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication8
Table 151. Rest of APAC: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication8
Table 152. Rest of APAC: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type9
Table 153. Rest of APAC: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type9
Table 154. Rest of APAC: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel9
Table 155. Rest of APAC: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel1
Table 156. Middle East and Africa: Generic Drugs Market - Revenue, 2021 - 2024 (US$ Billion) - by Molecule Type3
Table 157. Middle East and Africa: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type3
Table 158. Middle East and Africa: Generic Drugs Market - Revenue, 2021 - 2024 (US$ Billion) - by Indication4
Table 159. Middle East and Africa: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication4
Table 160. Middle East and Africa: Generic Drugs Market - Revenue, 2021 - 2024 (US$ Billion) - by Type5
Table 161. Middle East and Africa: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type5
Table 162. Middle East and Africa: Generic Drugs Market - Revenue, 2021 - 2024 (US$ Billion) - by Distribution Channel5
Table 163. Middle East and Africa: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel6
Table 164. Saudi Arabia: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type8
Table 165. Saudi Arabia: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type8
Table 166. Saudi Arabia: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication9
Table 167. Saudi Arabia: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication9
Table 168. Saudi Arabia: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type0
Table 169. Saudi Arabia: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type0
Table 170. Saudi Arabia: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel0
Table 171. Saudi Arabia: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel2
Table 172. South Africa: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type3
Table 173. South Africa: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type4
Table 174. South Africa: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication4
Table 175. South Africa: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication5
Table 176. South Africa: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type5
Table 177. South Africa: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type5
Table 178. South Africa: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel6
Table 179. South Africa: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel6
Table 180. United Arab Emirates: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type8
Table 181. United Arab Emirates: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type8
Table 182. United Arab Emirates: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication9
Table 183. United Arab Emirates: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication9
Table 184. United Arab Emirates: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type0
Table 185. United Arab Emirates: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type0
Table 186. United Arab Emirates: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel0
Table 187. United Arab Emirates: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel1
Table 188. Rest of Middle East and Africa: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type2
Table 189. Rest of Middle East and Africa: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type3
Table 190. Rest of Middle East and Africa: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication3
Table 191. Rest of Middle East and Africa: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication4
Table 192. Rest of Middle East and Africa: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type4
Table 193. Rest of Middle East and Africa: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type4
Table 194. Rest of Middle East and Africa: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel5
Table 195. Rest of Middle East and Africa: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel5
Table 196. South and Central America: Generic Drugs Market - Revenue, 2021 - 2024 (US$ Billion) - by Molecule Type7
Table 197. South and Central America: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type7
Table 198. South and Central America: Generic Drugs Market - Revenue, 2021 - 2024 (US$ Billion) - by Indication8
Table 199. South and Central America: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication9
Table 200. South and Central America: Generic Drugs Market - Revenue, 2021 - 2024 (US$ Billion) - by Type9
Table 201. South and Central America: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type9
Table 202. South and Central America: Generic Drugs Market - Revenue, 2021 - 2024 (US$ Billion) - by Distribution Channel0
Table 203. South and Central America: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel0
Table 204. Brazil: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type2
Table 205. Brazil: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type3
Table 206. Brazil: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication3
Table 207. Brazil: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication4
Table 208. Brazil: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type4
Table 209. Brazil: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type4
Table 210. Brazil: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel5
Table 211. Brazil: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel5
Table 212. Argentina: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type7
Table 213. Argentina: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type7
Table 214. Argentina: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication8
Table 215. Argentina: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication8
Table 216. Argentina: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type9
Table 217. Argentina: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type9
Table 218. Argentina: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel9
Table 219. Argentina: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel0
Table 220. Rest of South and Central America: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Molecule Type1
Table 221. Rest of South and Central America: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type1
Table 222. Rest of South and Central America: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Indication2
Table 223. Rest of South and Central America: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication2
Table 224. Rest of South and Central America: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Type3
Table 225. Rest of South and Central America: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Type3
Table 226. Rest of South and Central America: Generic Drugs Market - Revenue, 2021 - 2024(US$ Billion) - by Distribution Channel3
Table 227. Rest of South and Central America: Generic Drugs Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel4
Table 228. Glossary of Terms, Pharmaceutical Market1
List of Figures
Figure 1. Generic Drugs Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Generic Drugs Market Revenue (US$ Billion), 2021-2031
Figure 5. Generic Drugs Market Share (%) - by Molecule Type (2024 and 2031)
Figure 6. Antidepressants: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 7. Antihistamines: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 8. Analgesics: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 9. Antibiotics: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 10. Antivirals: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 11. Diuretics: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 12. Others: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 13. Generic Drugs Market Share (%) - by Indication (2024 and 2031)
Figure 14. Metabolic Diseases: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 15. Cancer: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 16. Immunology: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 17. Respiratory Disorder: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 18. Cardiovascular Disorder: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 19. Neurology Disorder: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 20. Rare Disease: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 21. Others: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 22. Generic Drugs Market Share (%) - by Type (2024 and 2031)
Figure 23. Prescription: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 24. OTC Drugs: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 25. Generic Drugs Market Share (%) - by Distribution Channel (2024 and 2031)
Figure 26. Hospital Pharmacies: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 27. Retail Pharmacies: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 28. Online Pharmacies: Generic Drugs Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 29. Generic Drugs Market Breakdown by Region, 2024 and 2031 (%)
Figure 30. North America: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 31. North America: Generic Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 32. United States: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 33. Canada: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 34. Mexico: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 35. Europe: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 36. Europe: Generic Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 37. United Kingdom: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 38. Germany: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 39. France: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 40. Italy: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 41. Spain: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 42. Rest of Europe: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 43. Asia Pacific: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 44. Asia Pacific: Generic Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 45. China: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 46. Japan: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 47. India: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 48. Australia: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 49. South Korea: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 50. Rest of APAC: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 51. Middle East and Africa: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 52. Middle East and Africa: Generic Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 53. Saudi Arabia: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 54. South Africa: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 55. United Arab Emirates: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 56. Rest of Middle East and Africa: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 57. South and Central America: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 58. South and Central America: Generic Drugs Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 59. Brazil: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 60. Argentina: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 61. Rest of South and Central America: Generic Drugs Market - Revenue, 2021 - 2031 (US$ Billion)

Companies Mentioned

Some of the leading companies in the Generic Drugs Market include:
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc
  • Dr. Reddy's Laboratories Ltd
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd
  • AbbVie Inc
  • AstraZeneca Plc
  • Sanofi SA
  • Aurobindo Pharma Ltd
  • Glenmark Pharmaceuticals Ltd.

Table Information

Report AttributeDetails
No. of Pages287
PublishedMay 2025
Forecast Period2024 - 2031
Estimated Market Value ( USD ) in 2024 $ 423.55 Billion
Forecasted Market Value ( USD ) by 2031 $ 594.99 Billion
Compound Annual Growth Rate5.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Europe Generic Drugs Market Size and Forecast, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Small Molecule, Drug Class, Route Of Administration, Type, Distribution Channel, and Country - Product Image

Europe Generic Drugs Market Size and Forecast, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Small Molecule, Drug Class, Route Of Administration, Type, Distribution Channel, and Country

  • Report
  • 205 Pages
  • Europe
From
Generic Oncology Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Generic Oncology Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 176 Pages
  • Global
Generic Oncology Drugs Market Report and Forecast 2023-2031 - Product Image

Generic Oncology Drugs Market Report and Forecast 2023-2031

  • Report
  • 160 Pages
  • Global
From
Specialty Generics Market by Product Type, Drug Delivery System, Molecule Type, Disease Indication, Distribution Channel - Global Forecast to 2030 - Product Image

Specialty Generics Market by Product Type, Drug Delivery System, Molecule Type, Disease Indication, Distribution Channel - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
Generic Drugs - Global Strategic Business Report - Product Image

Generic Drugs - Global Strategic Business Report

  • Report
  • 711 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.